Clincosm LogoSign in Get a demo

Glioma

Showing 26 - 50 of 370
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Grade Glioma, Glioma, Glioma, Malignant Trial in Phoenix (Temsirolimus)

Not yet recruiting
  • High Grade Glioma
  • +3 more
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
Mar 6, 2023

Solid Tumor, Haematological Malignancy, Malignancy Trial in United Kingdom (Entrectinib)

Recruiting
  • Solid Tumor
  • +10 more
  • Belfast, United Kingdom
  • +25 more
Mar 14, 2023

Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)

Recruiting
  • Solid Tumor
  • +11 more
  • Belfast, United Kingdom
  • +16 more
Mar 2, 2023

MRI-based Computer Aided Diagnosis Software (V1) for Glioma

Enrolling by invitation
  • Glioma
  • Primary Brain Tumor
    • Shanghai, Shanghai, China
      Zhen Fan
    Feb 11, 2023

    Cognition, Brain Tumor, Magnetic Resonance Imaging Trial in Gent, Leuven, Wilrijk (behavioral, diagnostic test, other)

    Not yet recruiting
    • Cognition
    • +5 more
    • Neurocognitive tests: WAIS digit span, HVLT-R, COWAT, MOCA, WAIS digit symbol substitution, TMT A&B, Stroop Color Word Test
    • +3 more
    • Gent, Belgium
    • +2 more
    Feb 3, 2023

    Intraoperative Ultrasound in Gross Total Resection of Gliomas

    Not yet recruiting
    • Glioma
    • intraoperative ultrasound
    • (no location specified)
    Feb 3, 2023

    Glioma Trial run by the National Cancer Institute (NCI) (pre-operative abemaciclib, Device for Cerebral Fluid Dialysate

    Recruiting
    • Glioma
    • pre-operative abemaciclib
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Glioma, Gliomas, High Grade Glioma Trial run by the National Cancer Institute (NCI) (3T MRI scanner)

    Recruiting
    • Glioma
    • +4 more
    • 3T MRI scanner
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

    Recruiting
    • Astrocytoma, Grades II, III and IV
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    Space Occupying Lesions of the Brain

    Recruiting
    • Brain Tumor
    • +2 more
    • MR-scans using a 3T Prisma and a 7T Terra scanner (Siemens, Erlangen Germany)
    • Bern, Switzerland
      Institute for Diagnostic and Interventional Neuroradiology, Univ
    Jan 26, 2023

    Glioma Trial in Paris (MRI)

    Not yet recruiting
    • Glioma
    • MRI
    • Paris, France
      Pitié-Salpetrière Hospital
    Jan 27, 2023

    Glioblastoma, Glioma Trial in Denmark, Netherlands, United States (Selinexor)

    Terminated
    Has Results
    • Glioblastoma
    • Glioma
    • Boston, Massachusetts
    • +5 more
    Jan 24, 2023

    Molecular Testing for MD Anderson Cancer Center Personalized

    Recruiting
    • Glioma
    • +4 more
    • Biospecimen Collection
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

    Completed
    Has Results
    • Glioma
    • +7 more
    • Neural stem cells loaded with an oncolytic adenovirus
    • Duarte, California
    • +1 more
    Dec 28, 2022

    Melanoma, Colorectal Cancer, Non-Small-Cell Lung Cancer Trial in Springdale, Nashville (PF-07799933, binimetinib, cetuximab)

    Recruiting
    • Melanoma
    • +4 more
    • Fayetteville, Arkansas
    • +23 more
    Jan 19, 2023

    CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

    Active, not recruiting
    • Central Nervous System Tumor, Pediatric
    • +8 more
    • EGFR806-specific chimeric antigen receptor (CAR) T cell
    • Seattle, Washington
      Seattle Children's Hospital
    Jan 18, 2023

    Brain Tumor Trial in Baltimore, Rochester (Exablate Model 4000)

    Recruiting
    • Glioblastoma
    • +2 more
    • Focused Ultrasound (Exablate Model 4000)
    • Miami, Florida
    • +5 more
    Jan 18, 2023

    Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

    Recruiting
    • Malignant Glioma of Brain
    • +8 more
    • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
    • Detroit, Michigan
      Henry Ford Health System
    Jan 9, 2023

    Glioma, Solid Tumor Trial in Beijing (GNC-039)

    Recruiting
    • Glioma
    • Solid Tumor
    • Beijing, Beijing, China
    • +5 more
    Jan 12, 2023

    Glioma Trial ([18F]DPA-714)

    Not yet recruiting
    • Glioma
    • (no location specified)
    Jan 4, 2023

    Medulloblastoma, CNS Tumor, Pediatric, Ependymoma Trial in Beijing

    Recruiting
    • Medulloblastoma
    • +5 more
      • Beijing, Beijing, China
        Beijing Tiantan Hosiptal
      Jan 3, 2023

      Glioma, High Grade Glioma, Glioma, Malignant Trial in Philadelphia (18F-Fluciclovine PET-MRI)

      Recruiting
      • Glioma
      • +4 more
      • 18F-Fluciclovine PET-MRI
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Dec 22, 2022

      Immune and Inflammatory Indices in Peripheral Blood Predict

      Recruiting
      • Glioma
      • Immune Suppression
      • Detection of Immune and Inflammatory Indices in Peripheral Blood
      • Beijing, Beijing, China
      • +2 more
      Dec 21, 2022

      Glioma Trial in Suzhou (Tumor Infiltrating Lymphocytes (TIL))

      Recruiting
      • Glioma
      • Tumor Infiltrating Lymphocytes (TIL)
      • Suzhou, Jiangsu, China
        The Second Affiliated Hospital of Soochow University
      Dec 19, 2022

      CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

      Recruiting
      • Central Nervous System Tumor
      • +10 more
      • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
      • Seattle, Washington
        Seattle Children's Hospital
      Dec 14, 2022